Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Sep 13, 2021 · 10-Q · 44 days after period end · 0001214659-21-009448
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$2.32M | -$1.32M |
| EPS Diluted | -$0.03 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jul 31, 2021 · filed Sep 13, 2021 · 44 d after period end
